FIELD: veterinary medicine.
SUBSTANCE: invention is intended for treatment of feline infectious peritonitis (FIP) caused by feline coronavirus (FCoV). A lyophilized form of a composition for preparing a solution for subcutaneous administration based on the nucleoside analog VS-121354 and Taurine amino acid as active ingredients using a solubilizer sodium betadexsulfobutylate and a pH-adjusting agent is proposed in the following ratio of components wt.%: nucleoside analog VS-121354 or its analogue 2.8–3.8, taurine 6.9–8.5, sodium betadexasulfobutylate 84.55–93.45.
EFFECT: technical result consists in increasing the shelf life and improving the consumer properties of the finished dosage form, reducing the severity of pain syndrome and local irritating reactions to the injection field, increasing the therapeutic efficacy by the synergy of the two active substances.
1 cl, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR THE TREATMENT OF FELINE INFECTIOUS PERITONITIS | 2021 |
|
RU2780097C1 |
| USE OF COMPOSITION IN PREVENTION AND/OR TREATMENT OF PATHOGENIC INFECTIONS IN ANIMALS | 2021 |
|
RU2809765C1 |
| STRAIN Feline coronavirus FOR CONTROLLING OF VACCINES IMMUNOGENIC ACTIVITY AND PRODUCING OF BOIPREPARATIONS FOR DIAGNOSIS OF INFECTIVE FELINE PERITONITIS | 2003 |
|
RU2250260C1 |
| OPHTHALMIC DROPS COMPOSITION | 2012 |
|
RU2623066C2 |
| COMPOSITION OF EYE DROPS | 2017 |
|
RU2753511C2 |
| SET OF SPECIFIC OLIGODEOXYRIBONUCLEOTIDE PRIMERS AND A FLUORESCENTLY LABELED PROBE FOR IDENTIFYING THE N GENE FRAGMENT ENCODING THE NUCLEOCAPSID PROTEIN OF THE FELINE CORONAVIRUS/FELINE INFECTIOUS PERITONITIS VIRUS (FCoV, FIP) | 2022 |
|
RU2802929C1 |
| RECOMBINANT PROTEIN FOR IMMUNIZATION AGAINST FELINE CORONAVIRUS | 2023 |
|
RU2808965C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
| FORMULA OF FELINE VACCINE | 2002 |
|
RU2312676C2 |
| SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON FIPRONIL AND UVEMON FOR TREATING ARACHKOENTOMOSES | 2014 |
|
RU2585384C2 |
